Phase Two, a division of TOMCO2 Systems Company

Phase Two manufactures and supplies cryogenic storage solutions for ultra-low temperature preservation of biological materials. The company specializes in liquid nitrogen cryo freezer systems maintaining temperatures from -150°C to -196°C, serving biobanking, pharmaceutical development, reproductive medicine, and research laboratories. Product portfolio includes Vapor Shippers for cold chain transport, Cryogenic Canister Freezers (CCF), Cryogenic Rack Freezers (CRF), and High-Capacity High Efficiency (HCHE) series freezers with capacities ranging from 20,000 to 107,000 vials. Systems feature advanced insulation, vacuum technology, automated controls, dual-level sensing, and touch-screen displays. Phase Two emphasizes next-generation design engineered from the ground up rather than legacy systems. Applications span cell and gene therapy, in vitro fertilization, vaccine storage, pharmaceutical and biotech development, biorepositories, and academic research. The company provides installation, training, validation support, preventive maintenance, and rapid-response technical service. Manufacturing capability includes production facilities for cryogenic equipment assembly and testing.